This topic contains a solution. Click here to go to the answer

Author Question: In IDEF1X, extended E-R model subtype entities are called ________. A) generic entities B) ... (Read 101 times)

Mr. Wonderful

  • Hero Member
  • *****
  • Posts: 866
In IDEF1X, extended E-R model subtype entities are called ________.
 
  A) generic entities
  B) category entities
  C) nonspecific entities
  D) category clusters

Question 2

In Microsoft Access, referential integrity constraints are created ________.
 
  A) by checking the Enforce Referential Integrity check box in the Edit Relationships dialog box
  B) by setting a property value on the foreign key in the table which contains it
  C) by setting a property value on the primary key in the Relationships window
  D) by setting a property value on the foreign key in the Relationships window.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

InfiniteSteez

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

B

Answer to Question 2

A




Mr. Wonderful

  • Member
  • Posts: 866
Reply 2 on: Jul 7, 2018
Great answer, keep it coming :)


amandanbreshears

  • Member
  • Posts: 320
Reply 3 on: Yesterday
Gracias!

 

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

For a complete list of videos, visit our video library